| Genomic Medicine |
1 |
1 |
| Breast Cancer |
0 |
0.76 |
| Colorectal Cancer |
0 |
0.67 |
| Lipids Management |
0 |
0.63 |
| Genetics |
0 |
0.54 |
| Hereditary Nonpolyposis Colorectal Cancer (HNPCC) |
0 |
0.54 |
| Ovarian Cancer |
0 |
0.5 |
| Cancer |
0 |
0.48 |
| Genetic Testing |
0 |
0.48 |
| Colon Cancer |
0 |
0.43 |
| Familial Hypercholesterolemia |
0 |
0.39 |
| Cardiovascular Risk Management |
0 |
0.36 |
| Breast |
0 |
0.34 |
| Hypercholesterolemia |
0 |
0.27 |
| Mastectomy |
0 |
0.2 |
| Preventive Screening |
0 |
0.2 |
| Quality of Life |
0 |
0.14 |
| Bowel Preparation |
0 |
0.07 |
| Cerebrovascular Accident |
0 |
0.07 |
| Colonoscopy |
0 |
0.07 |
| Cost-Benefit Analysis |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Medicare |
0 |
0.07 |
| Oophorectomy |
0 |
0.07 |
| Statins |
0 |
0.07 |
| Translational Research |
0 |
0.07 |